Latest Market News

Dalaroo Metals’ maiden sampling at Blue Lagoon reveals a district-scale critical minerals system with high-grade zirconium, hafnium, and rare earth elements over a 2.7km strike. The results validate historical data and position the project as a strategic asset in Greenland’s emerging critical minerals landscape.

1414 Degrees secures critical approvals from AEMO and ElectraNet for its 140 MW Aurora Battery Energy Storage System, advancing the project toward grid connection and commercial operation in 2026.

NobleOak Life Limited has increased its stamp duty provision to $6.5 million following a dispute with the Victorian State Revenue Office over exemption eligibility, prompting pricing changes and ongoing regulatory engagement.

Noble Helium has received a further unsecured loan of AUD 250,000 from its Executive Chair to support working capital, highlighting management’s confidence amid ongoing refinancing efforts.

Juno Minerals has reported significant gold assay results from rock chip channel sampling at its Mount Ida project, with values up to 6.60 g/t Au. These findings pave the way for a planned shallow drilling program to explore vein extensions.

MEC Resources Limited has extended the closing date for its Options Placement Offer to 3 February 2026, adjusting the timetable for issuing and listing new options.

Wellnex Life reports a $2.4 million EBITDA improvement in H1 FY26 and reaches breakeven by Q2, supported by strong Pain Away sales and expanded distribution.

Orthocell has increased its investment in Marine Biomedical to 11.7%, securing exclusive distribution rights to the innovative PearlBone™ technology as it nears FDA approval.

Qube Holdings confirms Macquarie Asset Management has extended the exclusivity period under their due diligence agreement, though no binding proposal is guaranteed.

Sunshine Metals has received a $634,302 first and final dividend from the liquidation of Pluton Resources, unlocking funds to progress exploration at its promising Sybil and Liontown gold projects.

Australian Ethical reported a slight 1% decline in funds under management to $14.08 billion for December 2025, balancing positive retail flows against institutional mandate losses and market headwinds.

Proteomics International has been granted a Canadian patent for its PromarkerEso blood test, a pioneering diagnostic tool for early detection of esophageal adenocarcinoma. This milestone strengthens its global intellectual property portfolio and paves the way for commercial expansion in North America.